Fingerprint
Dive into the research topics of 'Multicenter phase II study of the AKT inhibitor MK-2206 in recurrent or metastatic nasopharyngeal carcinoma from patients in the mayo phase II consortium and the cancer therapeutics research group (MC1079)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically